Connecting healthtech companies to strategic partners and capital to achieve growth & scale

Healthtech Leaders is an international industry ecosystem built to connect early and growth stage healthtech and digital health innovators with the capital, partners and expertise needed to grow their companies, develop their products and get them to market.

The Healthtech Leaders network are the founders and CEOs of the world’s most innovative healthtech, digital health and DTx startups, SMEs and leading companies.

They are joined by leading health and life science investors from across the USA and Europe who visit LSX events to identify and meet with the most exciting life science and healthcare innovators from across the globe.

Healthtech Leaders @ LSX World Congress USA attracts the highest quality digital health leaders from the biggest and best large pharma and big tech companies. Hear from global leaders at Novo Nordisk, Lundbeck, Sanofi and Ferring Pharmaceuticals.

No other healthtech event offers access to as many qualified healthtech investors. LSX Nordic Congress will be bringing over 150 of the world’s most active investors to Boston. Fundraising? There’s no better place to be.

Healthcare is converging! As the lines between healthtech/digital health, traditional medtech, and biopharma are blurring, LSX Nordic Congress is the only event in the world dedicated to covering all 3 areas and encouraging learning, partnering and networking across the whole healthcare ecosystem.

Healthtech Leaders @ LSX Nordic Congress has a more sophisticated, easier to use and more widely adopted 1-2-1 partnering platform than any other healthtech event. All our attendees are highly qualified and available to contact via a huge range of search criteria. Other events say they do ‘partnering’. We’re the experts at it.

Got a healthtech solution for biopharma? Healthtech Leaders is co-located with LSX’s long-running (9 years now) Biotech Leaders event. Meet you peers, meet investors but also meet C-suite execs from Europe’s leading biopharma companies who are actively looking for digital solutions.